Cart
sales@molnova.com
Epimedin C
CAS No. 110642-44-9
Epimedin C( —— )
Catalog No. M17144 CAS No. 110642-44-9
Epimedin C was metabolized via desugarization, dehydrogenation, hydrogenation, dehydroxylation, hydroxylation, demethylation and glucuronidation pathways in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 59 | In Stock |
|
| 10MG | 129 | In Stock |
|
| 25MG | 274 | In Stock |
|
| 50MG | 404 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEpimedin C
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpimedin C was metabolized via desugarization, dehydrogenation, hydrogenation, dehydroxylation, hydroxylation, demethylation and glucuronidation pathways in vivo.
-
DescriptionEpimedin C was metabolized via desugarization, dehydrogenation, hydrogenation, dehydroxylation, hydroxylation, demethylation and glucuronidation pathways in vivo. It has potential activity against osteoporosis by stimulating osteoblasts.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTGF-beta/Smad
-
TargetTGFBR
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number110642-44-9
-
Formula Weight822.8
-
Molecular FormulaC39H50O19
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (303.84 mM)
-
SMILESC[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]1[C@@H]([C@@H](O)[C@@H](O[C@H]1Oc1c(oc2c(c1=O)c(cc(c2CC=C(C)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)c1ccc(cc1)OC)C)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cui L, et al. Biomed Chromatogr. 2014 Oct;28(10):1306-12.
molnova catalog
related products
-
SIS3
Selective Smad3 inhibitor; attenuates TGF-β1-dependent Smad3 phosphorylation and Dna binding.
-
Hydroxysafflor yello...
Hydroxysafflor yellow A inhibited adipogenesis by increasing HSL promoter activities.
-
ITD-1
ITD-1 is a potent, selective TGF-β inhibitor that induces type II TGFβ receptor (TGFBR2) degradation with IC50 of 0.85 uM.
